Cohance Lifesciences Ltd
NSE: COHANCE BSE: 543064
₹311.95
(3.48%)
Mon, 06 Apr 2026, 00:31 pm
Market Cap115.5B
PE Ratio54.25
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCohance Lifesciences Balance Sheet
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Interest expense on debt | -27.89M | -203.22M | -114.06M | -84.31M | -127.98M | -74.50M | -123.50M |
| Pretax equity in earnings | 0 | — | — | — | 0 | 0 | 0 |
| Equity in earnings | 0 | 482.13M | 537.36M | 411.12M | 0 | 0 | 0 |
| Total assets | 7.83B | 11.75B | 14.77B | 18.31B | 19.67B | 22.55B | 30.32B |
| Total current assets | 3.90B | 3.92B | 5.65B | 11.28B | 10.11B | 12.53B | 8.53B |
| Cash and short term investments | 199.57M | 447.48M | 1.90B | 5.29B | 4.87B | 8.24B | 2.89B |
| Cash & equivalents | 110.19M | 140.75M | 96.53M | 473.06M | 658.60M | 505.00M | 886.70M |
| Short term investments | 89.38M | 306.73M | 1.81B | 4.81B | 4.21B | 7.74B | 2.00B |
| Total receivables, net | 2.01B | 1.53B | 1.54B | 2.85B | 1.78B | 1.91B | 3.81B |
| Accounts receivable - trade, net | 1.48B | 1.17B | 1.02B | 2.36B | 1.11B | 1.34B | 2.84B |
| Other receivables | 537.21M | 360.83M | 518.40M | 481.91M | 667.85M | 570.60M | 964.20M |
| Total inventory | 1.61B | 1.87B | 2.13B | 3.02B | 3.33B | 2.33B | 1.73B |
| Other current assets, total | 37.18M | 25.75M | 25.86M | 65.21M | 44.59M | 100.72M | — |
| Total non-current assets | 3.93B | 7.83B | 9.12B | 7.03B | 9.56B | 10.02B | 21.78B |
| Long term investments | 3.65M | 3.08B | 3.61B | 1.17B | 1.17B | 1.31B | 1.54B |
| Note receivable - long term | 2.94M | 2.63M | 2.20M | 700.00K | 225.00K | 100.00K | 46.60M |
| Investments in unconsolidated subsidiaries | 0 | 3.07B | 3.61B | 0 | 0 | 0 | 0 |
| Other investments | 705.00K | 705.00K | 705.00K | 1.17B | 1.17B | 1.31B | 1.49B |
| Net property/plant/equipment | 3.86B | 4.66B | 5.41B | 5.70B | 7.69B | 7.89B | 12.53B |
| Gross property/plant/equipment | 4.62B | 5.65B | 6.67B | 7.27B | 9.80B | 10.41B | 15.60B |
| Deferred tax assets | — | 19.44M | 24.67M | 14.75M | 14.01M | 8.10M | 5.50M |
| Net intangible assets | 26.85M | 29.40M | 25.91M | 22.36M | 621.90M | 619.30M | 7.19B |
| Goodwill, net | 0 | 0 | 0 | 0 | 0 | 602.50M | 6.55B |
| Other intangibles, net | 26.85M | 29.40M | 25.91M | 22.36M | 621.90M | 16.80M | 638.90M |
| Other long term assets, total | 41.52M | 45.55M | 47.93M | 126.95M | 59.12M | 193.60M | 519.90M |
| Short term debt | 827.94M | 944.42M | 1.07B | 682.24M | 650.77M | 437.70M | 1.03B |
| Current portion of LT debt and capital leases | 0 | 4.04M | 10.68M | 10.91M | 4.79M | 51.90M | 333.40M |
| Short term debt excl. current portion of LT debt | 827.94M | 940.38M | 1.06B | 671.33M | 645.98M | 385.80M | 700.00M |
| Accounts payable | 535.75M | 710.56M | 828.92M | 1.06B | 651.64M | 423.50M | 802.10M |
| Income tax payable | 1.10M | 52.54M | 0 | 36.42M | 2.94M | 0 | 11.00M |
| Long term debt | 0 | 917.64M | 363.30M | 289.03M | 52.64M | 212.40M | 1.76B |
| Long term debt excl. lease liabilities | 0 | 917.64M | 363.30M | 289.03M | 52.64M | 212.40M | 1.76B |
| Total equity | 5.90B | 8.45B | 11.81B | 15.27B | 17.35B | 20.51B | 18.41B |
| Shareholders' equity | 5.90B | 8.45B | 11.81B | 15.27B | 17.35B | 20.51B | 16.97B |
| Common equity, total | 5.90B | 8.45B | 11.81B | 15.27B | 17.35B | 20.51B | 16.97B |
| Other common equity | 642.77M | 942.88M | 1.09B | 1.19B | 1.35B | 1.51B | 1.78B |
| Total debt | 827.94M | 1.86B | 1.43B | 971.27M | 703.41M | 650.10M | 2.79B |
| Net debt | 628.37M | 1.41B | -472.11M | -4.31B | -4.17B | -7.59B | -99.70M |
| Change in accounts receivable | -848.91M | 346.18M | 133.61M | -1.36B | 1.24B | 128.20M | -1.48B |
| Change in taxes payable | — | — | — | — | — | — | — |
| Change in accounts payable | 98.54M | 171.29M | 119.45M | 232.03M | -407.26M | -225.20M | 417.00M |
| Change in other assets/liabilities | 38.00M | 193.22M | -112.71M | 12.55M | -487.10M | 0 | 0 |
| Sale of fixed assets & businesses | — | 1.34M | 336.00K | 6.00K | 720.00K | 0 | 0 |
| Purchase/sale of investments, net | -68.98M | -3.25B | -2.01B | -560.72M | 844.74M | -3.12B | 6.28B |
| Sale/maturity of investments | — | 0 | 0 | 2.44B | 844.78M | 2.41B | 9.76B |
| Purchase of investments | -68.98M | -3.25B | -2.01B | -3.00B | -44.00K | -5.53B | -3.48B |
| Other investing cash flow items, total | -19.94M | 150.11M | -27.00K | -48.44M | 5.52M | 0 | 0 |
| Issuance/retirement of debt, net | 517.84M | 1.02B | -415.34M | -481.94M | -263.68M | -315.90M | 227.90M |
| Issuance/retirement of long term debt | 520.30M | 912.52M | -547.26M | -95.97M | -237.57M | -45.50M | -18.50M |
| Issuance/retirement of short term debt | -2.46M | 106.03M | 131.93M | -385.97M | -26.11M | -270.40M | 246.40M |
| Issuance/retirement of other debt | — | — | — | — | — | — | — |
| Total cash dividends paid | -230.17M | -767.23M | -254.56M | -1.02B | -2.04B | 0 | 0 |
| Other financing cash flow items, total | 0 | -839.00K | -159.00K | 241.00K | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800